CD8A and neoplasm: Furthermore, castalagin, which is enriched in bacteria associated with effective immunotherapeutic responses (e.g., family Ruminococcaceae and genus Alistipes), improves the ratio of CD8+ cells to FOXP3+CD4+ cells in the tumor microenvironment (Messaoudene et al., 2022).